Cambridge Probiotic & Antibiotic Trial 1

Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: A double-blind, placebo-controlled pilot study

Aim

This randomised, double blind, placebo-controlled study investigated the effect of Lab4 probiotic supplementation on the gut microbiota composition and prevention of pathogenic microorganisms overgrowth in response to antibiotic therapy.

Method

• The study was carried out at Addenbrooke’s Hospital in Cambridge.
• 22 patients requiring antibiotic therapy were divided into three groups
• Stool analysis was then conducted over a 28-day period to assess the different populations of bacteria in the gut microbiota.

Cambridge Probiotic/Antibiotic Trial 1 Group Table
Cambridge Probiotic/Antibiotic Trial 1 Group Table

The results

  1. The total numbers of facultative anaerobes:
  • significantly increased in the patients on antibiotics and placebo at the end of the antibiotic treatment (*P<0.05) and remained increased post antibiotic therapy (*P<0.05) (Group 1).
  • significantly increased in the patients on antibiotics and placebo at the end of the antibiotic treatment (*P<0.05), but the numbers decreased significantly after introducing Lab4 probiotic supplementation post antibiotic (*P<0.05) (Group 2).
  • remained stable in the patients on antibiotics and Lab4 probiotics throughout the study period (Group 3).
The Cambridge Probiotic/Antibiotic Trial 1 Total number of ‘undesirable’ facultative anaerobes
Total number of ‘undesirable’ facultative anaerobes
2. Lab4 supplementation reduced the overgrowth population of coliforms, enterococci and  staphylococci in the re-growth microbiota following antibiotic therapy.
Cambridge Probiotic & Antibiotic Trial 1 Post antibiotic therapy Total number of faecal coliforms, enterococci and staphylococci
Post antibiotic therapy Total number of faecal coliforms, enterococci and staphylococci

Conclusion

The supplementation of Lab4 probiotics alongside antibiotic therapy has been shown to reduce the overgrowth of undesirable and potentially harmful bacteria both during and following antibiotic therapy.

Reference

Madden JAJ et al 2005. Effects of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: A double-blind, placebo-controlled pilot study.
 Int Immunopharmacology 5:1091-1097​

Practitioner Accounts

Get access to our new ProVen Probiotics Practitioner Range

Apply Now

View More Studies

ProVen Probiotics are supported by a large body of research, which includes both in-vivo and in-vitro trials...

View Studies
Close Menu

Areas of Research

Category Menu Immunity
Immunity
Category Menu Gastro Intestinal Health
Gastro-Intestinal Health
Category Menu Early Immune System Development
Early Immune System Development
Category Menu Cognitive Function
Cognitive
Category Menu Performance
Performance
Category Menu Safety
Safety
ProVen Probiotics in-vitro, ex-vivo and animal studies
Other